Track-And-Trace Will Not Hitch A Ride On The User Fee Train
This article was originally published in The Pink Sheet Daily
Executive Summary
Efforts to reach a consensus proposal have been unsuccessful as the bill nears a possible final vote in the House.
You may also be interested in...
Rx Supply Chain Bill On Track In Senate; Will House Use The Same Gauges?
Track-and-trace measure goes to floor coupled to compounding bill, but the all-smiles markup in the Senate HELP Committee is more than made up for by the differences that remain with the House version.
Track and Trace: Draft Senate Bill Requires Unit-level System In 10 Years; House Opts For Study
The difference in approach to unit-level tracing underscores the difficulty supporters of a national track-and-trace program face in gaining final approval of a bill before manufacturers go too far down the road in implementing a California pedigree law that goes into effect in 2015.
Draft Guidances For 2013 Will Grapple With Biosimilars, Track and Trace, Compounding
FDA’s Center for Drug Evaluation and Research plans to publish more than 50 new and revised draft guidances this calendar year.